New vaginal treatment tested to reverse cervical Pre-Cancer
Disease control
Recruiting now
This study is testing whether artesunate vaginal inserts can help treat cervical pre-cancer (CIN2/3) and clear the HPV infection that causes it. About 78 women will use either the active inserts or a placebo for three 5-day cycles. The main goal is to see if the treatment causes …
Phase: PHASE2 • Sponsor: Frantz Viral Therapeutics, LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC